Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote Benzinga 15:13 Fri, 31 Jul Article paywall
STAT Plus: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more STAT 14:32 Fri, 31 Jul
FDA Advisory Panel Backs Replimune's RP1, Bringing The Melanoma Therapy One Step Closer To Approval RTT News 10:23 Fri, 31 Jul
Securities Fraud Investigation Into Replimune Group Inc. (Repl) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire (Press Release) 20:17 Wed, 29 Jul
Replimune Group Inc. (Repl) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire (Press Release) 20:07 Wed, 29 Jul
Securities Fraud Investigation Into Replimune Group Inc. (Repl) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire (Press Release) 01:46 Wed, 29 Jul
Replimune’s rollercoaster: FDA adcom signals another bumpy ride BioWorld 22:13 Tue, 28 Jul Article paywall
Replimune shares fall after FDA reviewers raise doubts over RP1 melanoma drug efficacy Proactive Investors (US) 18:04 Tue, 28 Jul
